Océanie · Actualité · The Mercury

Argent BioPharma sets four priorities as it eyes healthy ageing research

Publié par The Mercury · Australie il y a 11 h

Argent BioPharma (ASX:RGT) has listed four strategic priorities following the global licensing of CannEpil, expansion of its pharmaceutical development programs and continued…

Lire l'article complet sur The Mercury Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.themercury.com.au)

Argent BioPharma sets four priorities as it eyes healthy ageing research

À lire aussi

'Extreme' sect reported years before young girl's death

King River goes deep with 11,000m WA Murchison gold assault

This economist believes the system is broken. Maybe she has a point

Senior police officer facing sack over claims of rough, non-consensual sex

Senior police officer facing sack over claims of rough, non-consensual sex

The words that should haunt Canberrans in the wake of this awful sentencing

Argent BioPharma sets four priorities as it eyes healthy ageing research

Partager

À lire aussi

'Extreme' sect reported years before young girl's death

King River goes deep with 11,000m WA Murchison gold assault

This economist believes the system is broken. Maybe she has a point

Senior police officer facing sack over claims of rough, non-consensual sex

Senior police officer facing sack over claims of rough, non-consensual sex

The words that should haunt Canberrans in the wake of this awful sentencing